References
- Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature 290:457–65
- Basso D, Navaglia F, Fogar P, Zambon CF, Greco E, Schiavon S, Fasolo M, et al. (2007). DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta 381:50–5
- Bosch FX, Ribes J, Díaz M, Cléries R. (2004). Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127:S5–S16
- Chen JG, Zhang SW. (2011). Liver cancer epidemic in China: Past, present and future. Semin Cancer Biol 21:59–69
- Chen R, Wang H, Li S, Ren Y. (2013). Mitochondrial DNA mutations may not be frequent in patients with polycystic ovary syndrome. Mitochondrial DNA 24:418–19
- Croteau DL, Bohr VA. (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272:25409–12
- Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL. (2008). The Vienna RNA Website. Nucleic Acids Res 1:W70–4
- Jin Y, Yu Q, Zhou D, Chen L, Huang X, Xu G, Huang J, et al. (2012). The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population. Genet Test Mol Biomarkers 16:330–4
- Komandur S, Venkatasubramanian S, Alluri RV, Rao P, Rao P, Hasan Q. (2011). Mitochondrial insertion-deletion polymorphism: role in disease pathology. Genet Test Mol Biomarkers 15:361–4
- Kong QP, Bandelt HJ, Sun C, Yao YG, Salas A, Achilli A, Wang CY, et al. (2006). Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet 15:2076–86
- Krishnan KJ, Turnbull DM. (2010). Mitochondrial DNA and genetic disease. Essays Biochem 47:139–51
- Peng TI, Yu PR, Chen JY, Wang HL, Wu HY, Wei YH, Jou MJ. (2006). Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta 1762:241–55
- van Oven M, Kayser M. (2009). Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30:E386–94
- Villanueva A, Hernandez-Gea V, Llovet JM. (2013). Medical therapies for hepatocellular carcinoma: A critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34–42
- Wallace DC. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet 39:359–407
- Wrischnik LA, Higuchi RG, Stoneking M, Erlich HA, Arnheim N, Wilson AC. (1987). Length mutations in human mitochondrial DNA: Direct sequencing of enzymatically amplified DNA. Nucleic Acids Res 15:529–42
- Yao YG, Watkins WS, Zhang YP. (2000). Evolutionary history of the mtDNA 9-bp deletion in Chinese populations and its relevance to the peopling of east and southeast Asia. Hum Genet 107:504–12
- Zhuo G, Feng G, Leng J, Yu L, Jiang Y. (2010). A 9-bp deletion homoplasmy in women with polycystic ovary syndrome revealed by mitochondrial genome-mutation screen. Biochem Genet 48:157–63